Skip to main content
Erschienen in:

01.05.2014 | Leitthema

Neurodermitis oder Hyper-IgE-Syndrom?

verfasst von: B. Hagl, A.C. Boos, V. Heinz, A. Schlesinger, B.D. Spielberger, PD Dr. E.D. Renner

Erschienen in: hautnah | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Ekzem und erhöhtes Immunglobulin E (IgE) im Serum sind meist die ersten Symptome, die den Verdacht auf ein Hyper-IgE-Syndrom aufkommen lassen. Doch wann ist es Neurodermitis und wann muss an angeborene Immundefekte wie die Hyper-IgE-Syndrome gedacht werden? Hyper-IgE-Syndrome sind selten, aber eine frühe Diagnosestellung ist lebenswichtig für den einzelnen Patienten. Es ist deshalb von großer Bedeutung genauer hinzusehen, die Besonderheiten der Hyper-IgE-Syndrome zu (er)kennen und die richtigen Konsequenzen für den individuellen Patienten zu ziehen.
Literatur
1.
Zurück zum Zitat Davis SD, Schaller J, Wedgwood RJ (1966) Job’s syndrome. Recurrent, „cold“, staphylococcal abscesses. Lancet 1:1013–1015PubMedCrossRef Davis SD, Schaller J, Wedgwood RJ (1966) Job’s syndrome. Recurrent, „cold“, staphylococcal abscesses. Lancet 1:1013–1015PubMedCrossRef
2.
Zurück zum Zitat Buckley RH, Wray BB, Belmaker EZ (1972) Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49:59–70PubMed Buckley RH, Wray BB, Belmaker EZ (1972) Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49:59–70PubMed
3.
Zurück zum Zitat Renner ED, Puck JM, Holland SM et al (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93–99PubMedCrossRef Renner ED, Puck JM, Holland SM et al (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93–99PubMedCrossRef
4.
Zurück zum Zitat Minegishi Y, Saito M, Morio T et al (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25:745–755PubMedCrossRef Minegishi Y, Saito M, Morio T et al (2006) Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25:745–755PubMedCrossRef
5.
Zurück zum Zitat Sowerwine KJ, Holland SM, Freeman AF (2012) Hyper-IgE syndrome update. Ann N Y Acad Sci 1250:25–32PubMedCrossRef Sowerwine KJ, Holland SM, Freeman AF (2012) Hyper-IgE syndrome update. Ann N Y Acad Sci 1250:25–32PubMedCrossRef
6.
Zurück zum Zitat Minegishi Y, Saito M, Tsuchiya S et al (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448:1058–1062PubMedCrossRef Minegishi Y, Saito M, Tsuchiya S et al (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448:1058–1062PubMedCrossRef
7.
Zurück zum Zitat Holland SM, DeLeo FR, Elloumi HZ et al (2007) STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357:1608–1619PubMedCrossRef Holland SM, DeLeo FR, Elloumi HZ et al (2007) STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 357:1608–1619PubMedCrossRef
8.
Zurück zum Zitat Renner ED, Torgerson TR, Rylaarsdam S et al (2007) STAT3 mutation in the original patient with Job’s syndrome. N Engl J Med 357:1667–1668PubMedCrossRef Renner ED, Torgerson TR, Rylaarsdam S et al (2007) STAT3 mutation in the original patient with Job’s syndrome. N Engl J Med 357:1667–1668PubMedCrossRef
9.
Zurück zum Zitat Renner ED, Rylaarsdam S, Anover-Sombke S et al (2008) Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 122:181–187PubMedCrossRef Renner ED, Rylaarsdam S, Anover-Sombke S et al (2008) Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol 122:181–187PubMedCrossRef
10.
Zurück zum Zitat Chandesris MO, Melki I, Natividad A et al (2012) Autosomal dominant STAT3 deficiency and hyper-ige syndrome: molecular, cellular, and clinical features from a french national survey. Medicine (Baltimore) 91:e1–e19 Chandesris MO, Melki I, Natividad A et al (2012) Autosomal dominant STAT3 deficiency and hyper-ige syndrome: molecular, cellular, and clinical features from a french national survey. Medicine (Baltimore) 91:e1–e19
11.
Zurück zum Zitat Schimke LF, Sawalle-Belohradsky J, Roesler J et al (2010) Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol 126:611–617 e1PubMedCrossRef Schimke LF, Sawalle-Belohradsky J, Roesler J et al (2010) Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol 126:611–617 e1PubMedCrossRef
12.
Zurück zum Zitat Milner JD, Brenchley JM, Laurence A et al (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773–776PubMedCentralPubMedCrossRef Milner JD, Brenchley JM, Laurence A et al (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773–776PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Minegishi Y, Karasuyama H (2008) Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep 8:386–391PubMedCrossRef Minegishi Y, Karasuyama H (2008) Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep 8:386–391PubMedCrossRef
14.
Zurück zum Zitat Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S et al (2012) A patient with tyrosine kinase 2 deficiency without Hyper-IgE Syndrome. J Pediatr 160:1055–1057PubMedCentralPubMedCrossRef Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S et al (2012) A patient with tyrosine kinase 2 deficiency without Hyper-IgE Syndrome. J Pediatr 160:1055–1057PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Engelhardt KR, McGhee S, Winkler S et al (2009) Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 124:1289–1302 e4PubMedCentralPubMedCrossRef Engelhardt KR, McGhee S, Winkler S et al (2009) Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 124:1289–1302 e4PubMedCentralPubMedCrossRef
17.
18.
19.
Zurück zum Zitat Meyer-Bahlburg A, Renner ED, Rylaarsdam S et al (2012) Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. J Allergy Clin Immunol 129:559–562 e2PubMedCrossRef Meyer-Bahlburg A, Renner ED, Rylaarsdam S et al (2012) Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. J Allergy Clin Immunol 129:559–562 e2PubMedCrossRef
20.
Zurück zum Zitat Speckmann C, Enders A, Woellner C et al (2008) Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol 129:448–454PubMedCrossRef Speckmann C, Enders A, Woellner C et al (2008) Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol 129:448–454PubMedCrossRef
21.
Zurück zum Zitat Freeman AF, Renner ED, Henderson C et al (2013) Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol 33:896–902PubMedCrossRef Freeman AF, Renner ED, Henderson C et al (2013) Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol 33:896–902PubMedCrossRef
22.
Zurück zum Zitat Bittner TC, Pannicke U, Renner ED et al (2010) Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr 222:351–355PubMedCrossRef Bittner TC, Pannicke U, Renner ED et al (2010) Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr 222:351–355PubMedCrossRef
23.
Zurück zum Zitat Goussetis E, Peristeri I, Kitra V et al (2010) Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol 126:392–394PubMedCrossRef Goussetis E, Peristeri I, Kitra V et al (2010) Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol 126:392–394PubMedCrossRef
24.
Zurück zum Zitat Boztug H, Karitnig-Weiss C, Ausserer B et al (2012) Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. Pediatr Hematol Oncol 29:585–594PubMed Boztug H, Karitnig-Weiss C, Ausserer B et al (2012) Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen. Pediatr Hematol Oncol 29:585–594PubMed
Metadaten
Titel
Neurodermitis oder Hyper-IgE-Syndrom?
verfasst von
B. Hagl
A.C. Boos
V. Heinz
A. Schlesinger
B.D. Spielberger
PD Dr. E.D. Renner
Publikationsdatum
01.05.2014
Verlag
Springer Vienna
Erschienen in
hautnah / Ausgabe 2/2014
Print ISSN: 1866-2250
Elektronische ISSN: 2192-6484
DOI
https://doi.org/10.1007/s12326-013-0092-y

Weitere Artikel der Ausgabe 2/2014

hautnah 2/2014 Zur Ausgabe